Tecentriq (atezolizumab)
Drug company: Genentech
877-436-3683
Genentech offers 2 financial assistance programs for patients who have been prescribed Tecentriq:
Genentech Oncology Co-pay Assistance Program
Genentech Patient Foundation
Turalio (pexidartinib) Capsules
Drug company: Daiichi-Sankyo
866-437-4669
Daiichi-Sankyo offers 2 financial assistance programs for patients who have been prescribed Turalio:
Turalio Copay Program
Turalio Patient Assistance Program
Votrient (pazopanib) Tablets
Drug company: Novartis
800-282-7630
Novartis Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using Votrient:
Novartis Oncology Universal Co-pay Program
Novartis Patient Assistance Foundation
Yondelis (trabectedin)
Drug company: Janssen
844-966-3354
Janssen offers 2 financial assistance programs for patients using Yondelis:
Janssen CarePath Savings Program
Johnson & Johnson Patient Assistance Foundation
Table. Drugs Prescribed for Soft-Tissue Sarcoma/Tenosynovial Giant-Cell Tumor
- Drug name (generic name)
- Drug company
- Indications
- Patient support services
- Tecentriq (atezolizumab)
- Genentech
- Treatment of adult and pediatric patients 2 years of age and older with unresectable or metastatic alveolar soft part sarcoma
- Genentech Oncology
Co-pay Assistance
Program
Genentech Patient Foundation
Drug name (generic name)
Drug company
Indications
Patient support services
- Turalio (pexidartinib) Capsules
- Daiichi-Sankyo
- Treatment of symptomatic tenosynovial giant-cell tumor
- Turalio Copay Program
800-850-4306
Turalio Patient Assistance Program
866-437-4669
Drug name (generic name)
Drug company
Indications
Patient support services
- Votrient (pazopanib) Tablets
- Novartis
- Advanced soft-tissue sarcoma
- Novartis Oncology Universal Co-pay Program
877-577-7756
Novartis Patient Assistance Foundation
800-277-2254
Drug name (generic name)
Drug company
Indications
Patient support services
- Yondelis (trabectedin)
- Janssen
- Unresectable or metastatic liposarcoma or leiomyosarcoma, after an anthracycline-containing regimen
- Janssen CarePath Savings Program
844-966-3354
Johnson & Johnson Patient Assistance Foundation
800-652-6227
Drug name (generic name)
Drug company
Indications
Patient support services